Grant

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

CountryUnited States
Deadline2027-12-23 (396 days left)
Published2024-11-22
SectorsHealth & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity RFA-HL-26-018. CFDA: 93.855, 93.838, 93.233, 93.837, 93.839

The buyer, the value, the full description and the link to the official notice are available with a free account.